These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28328115)

  • 1. Association of NPC1 variant p.P237S with a pathogenic splice variant in two Niemann-Pick disease type C1 patients.
    Salman A; Cougnoux A; Farhat N; Wassif CA; Porter FD
    Am J Med Genet A; 2017 Apr; 173(4):1038-1040. PubMed ID: 28328115
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and genetic special features of Niemann-Pick disease, type C].
    Zakharova EIu; Mikhaĭlova SV; Proshliakova TIu; Rudenskaia GE
    Vestn Ross Akad Med Nauk; 2012; (12):60-5. PubMed ID: 23530428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical course of adult visceral Niemann-Pick type C1 disease. A rare or underdiagnosed disorder?
    Dvorakova L; Sikora J; Hrebicek M; Hulkova H; Bouckova M; Stolnaja L; Elleder M
    J Inherit Metab Dis; 2006 Aug; 29(4):591. PubMed ID: 16802107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of NPC1 function in a patient with a co-inherited novel insulin receptor mutation does not grossly modify the severity of the associated insulin resistance.
    Kirk J; Porter KM; Parker V; Barroso I; O'Rahilly S; Hendriksz C; Semple RK
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3(Suppl 3):S227-32. PubMed ID: 20521171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in NPC1 in two Brazilian patients with Niemann-Pick disease type C and progressive supranuclear palsy-like presentation.
    Godeiro-Júnior C; Inaoka RJ; Barbosa MR; Silva MR; Aguiar Pde C; Barsottini O
    Mov Disord; 2006 Dec; 21(12):2270-2. PubMed ID: 17044092
    [No Abstract]   [Full Text] [Related]  

  • 6. Rescue of an in vitro neuron phenotype identified in Niemann-Pick disease, type C1 induced pluripotent stem cell-derived neurons by modulating the WNT pathway and calcium signaling.
    Efthymiou AG; Steiner J; Pavan WJ; Wincovitch S; Larson DM; Porter FD; Rao MS; Malik N
    Stem Cells Transl Med; 2015 Mar; 4(3):230-8. PubMed ID: 25637190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele.
    Praggastis M; Tortelli B; Zhang J; Fujiwara H; Sidhu R; Chacko A; Chen Z; Chung C; Lieberman AP; Sikora J; Davidson C; Walkley SU; Pipalia NH; Maxfield FR; Schaffer JE; Ory DS
    J Neurosci; 2015 May; 35(21):8091-106. PubMed ID: 26019327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets.
    Wassif CA; Cross JL; Iben J; Sanchez-Pulido L; Cougnoux A; Platt FM; Ory DS; Ponting CP; Bailey-Wilson JE; Biesecker LG; Porter FD
    Genet Med; 2016 Jan; 18(1):41-8. PubMed ID: 25764212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of 30 Niemann-Pick type C patients from Spain.
    Macías-Vidal J; Rodríguez-Pascau L; Sánchez-Ollé G; Lluch M; Vilageliu L; Grinberg D; Coll MJ;
    Clin Genet; 2011 Jul; 80(1):39-49. PubMed ID: 20718790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Niemann-Pick C1 modulates hepatic triglyceride metabolism and its genetic variation contributes to serum triglyceride levels.
    Uronen RL; Lundmark P; Orho-Melander M; Jauhiainen M; Larsson K; Siegbahn A; Wallentin L; Zethelius B; Melander O; Syvänen AC; Ikonen E
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1614-20. PubMed ID: 20489167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Mediated Generation of Niemann-Pick C1 Knockout Cell Line.
    Du X; Lukmantara I; Yang H
    Methods Mol Biol; 2017; 1583():73-83. PubMed ID: 28205168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New mutation in a young woman diagnosed with Niemann-Pick disease type C].
    Lario A; de Miguel C; Ojeda E; Gil S; Coll MJ; Alfonso P
    Med Clin (Barc); 2016 Jun; 146(11):494-6. PubMed ID: 27016452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
    Cougnoux A; Cluzeau C; Mitra S; Li R; Williams I; Burkert K; Xu X; Wassif CA; Zheng W; Porter FD
    Cell Death Dis; 2016 Mar; 7(3):e2147. PubMed ID: 26986514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do GWAS and studies of heterozygotes for NPC1 and/or NPC2 explain why NPC disease cases are so rare?
    Erickson RP
    J Appl Genet; 2018 Nov; 59(4):441-447. PubMed ID: 30209687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid whole-genome sequencing identifies a novel homozygous
    Hildreth A; Wigby K; Chowdhury S; Nahas S; Barea J; Ordonez P; Batalov S; Dimmock D; Kingsmore S;
    Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28550066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Niemann-Pick disease type C caused by NPC1 mutation in a case].
    Zhang G; Yu F; Zhang K; Li F; Lyu Y; Gao M; Gai Z; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 May; 36(5):480-483. PubMed ID: 31030438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotide treatment for a pseudoexon-generating mutation in the NPC1 gene causing Niemann-Pick type C disease.
    Rodríguez-Pascau L; Coll MJ; Vilageliu L; Grinberg D
    Hum Mutat; 2009 Nov; 30(11):E993-E1001. PubMed ID: 19718781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of oxysterol-derived pharmacological chaperones for Niemann-Pick type C1 protein.
    Ohgane K; Karaki F; Noguchi-Yachide T; Dodo K; Hashimoto Y
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3480-5. PubMed ID: 24928400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel NPC1 mutations with different segregation in two related Greek patients with Niemann-Pick type C disease: molecular study in the extended pedigree and clinical correlations.
    Bountouvi E; Papadopoulou A; Vanier MT; Nyktari G; Kanellakis S; Michelakakis H; Dinopoulos A
    BMC Med Genet; 2017 May; 18(1):51. PubMed ID: 28472934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann-Pick type C patients carrying missense mutations.
    Macías-Vidal J; Girós M; Guerrero M; Gascón P; Serratosa J; Bachs O; Coll MJ
    FEBS J; 2014 Oct; 281(19):4450-66. PubMed ID: 25131710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.